top of page

Innovating to improve care standards in the NICU and beyond

Extravasation injury (EVI), or the unwanted leakage of life preserving but caustic IV contents into surrounding tissue, is a devastating and far too common injury experienced by NICU patients, it is especially prevalent and impactful in the premature baby population. EVI can require surgical intervention and result in lifelong complications such as scarring, restricted mobility, and amputation. EVI also impedes the delivery of live preserving drugs and nutrition, which is particularly critical for premature babies reliant on intravenous sustenance.

“Extravasation and infiltration iniuries often lead to disastrous complications if not recognised early.”

Prof. Sanjay Patole

Clinical Prof. of Neonatal Paediatrics,

King Edwards Memorial Hospital

  • Graded chemical burn

  • Blistering to amputation

  • Delayed drug delivery

  • Longer hospital stay

  • Lifelong disability

image duotone 05.jpg

Problem

Solution

Pretect is developing a novel non-invasive continuous monitoring device for detection of PIV infiltration and extravasation in our first indication, preterm and term infants, with the aim of preventing EVI.

​

Pretect devices is driven through personal and professional passion to enhance NICU life support procedures via rapid detection of IV leakage by automatically shutting off the IV pump and alerting healthcare staff to correct IV line integrity. Pretect's solution is integrated into the current NICU workflow and reduces the workload of nurses enabling a higher level of healthcare. In 2021 the Australian Commission on Safety and Quality in Health Care introduced new clinical care standards for IV catheter management. Our innovation will be a pioneering solution for implementing this new standard across Australia in the NICU and beyond.

PRElogo stacked light bg.png
image_edited_edited.png

Introducing our EVI prevention solution, the Vedette  , a revolutionary device that rapidly detects leakage of peripheral IV fluids. Vedette   is purposely designed for our first target population, NICU babies, to prevent devastating chemical burns and maintain IV line integrity. 

TM

TM

features-removebg-preview.png

Pretect Devices would like to acknowledge its valued supporters and partners.

Overall winners (2021)

Biodesign NEXT extension funding (2022)

Innovation Booster Grant winners (2022 and 2024)

Medtech Actuator Accelerator alumni (2023) - Cohort eight

Finalists - Emerging Innovation Category (2024)

We acknowledge the Traditional Owners of the land where we work and live. We pay our respects to Elders past, present and emerging. We celebrate the stories, culture and traditions of Aboriginal and Torres Strait Islander Elders of all communities who also work and live on this land.

bottom of page